Evidence map›Paper›PMID 35831113›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Autoimmune Pulmonary Alveolar Proteinosis during the Treatment of Idiopathic Inflammatory Myopathy.

Naoki Shijubou, Takeyuki Sawai, Taku Hatakeyama, Satoru Munakata, Masami Yamazoe, Hirofumi Chiba

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Naoki ShijubouDepartment of Respiratory Medicine, Hakodate Municipal Hospital, Japan.
Takeyuki SawaiDepartment of Respiratory Medicine, Hakodate Municipal Hospital, Japan.
Taku HatakeyamaDepartment of Respiratory Medicine, Hakodate Municipal Hospital, Japan.
Satoru MunakataDepartment of Pathology, Hakodate Municipal Hospital, Japan.
Masami YamazoeDepartment of Respiratory Medicine, Hakodate Municipal Hospital, Japan.
Hirofumi ChibaDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Japan.
Hakodate National Hospital · JPSapporo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 50% of idiopathic inflammatory myopathies (IIMs) are associated with interstitial lung disease (ILD). Typically, IIM-ILD manifests as nonspecific interstitial pneumonia. We herein report a rare case of a 78-year-old man with autoimmune pulmonary alveolar proteinosis (PAP) that developed during IIM treatment. The diagnosis of autoimmune PAP was based on detecting anti-granulocyte-macrophage colony-stimulating factor antibodies. We postulated that PAP may have been induced by IIM treatment with prednisolone. Our case suggests that the possibility of autoimmune PAP should be considered in patients with lung lesions during the clinical course of IIM.

Indexed as

Autoimmune DiseasesLung Diseases, InterstitialMyositisPulmonary Alveolar ProteinosisAgedAutoantibodiesHumansMaleAutoantibodiesanti-macrophage colony-stimulating factor antibodiesautoimmune pulmonary alveolar proteinosisidiopathic inflammatory myopathies

Identifiers

PMID35831113
PMCPMC9970810
OpenAlexW4285412879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.